Allay Therapeutics

Allay Therapeutics is a clinical-stage biotechnology company dedicated to developing pain-relief drugs to transform postoperative pain management and recovery for patients, alleviating their suffering. The company is advancing its first candidate drug, ATX-101. ATX-101 is a small, dissolvable product containing the proven local anesthetic bupivacaine. It is designed for use during surgery to provide sustained, localized pain relief.